UVXY Stock News 44.50 05/18/2014 18:57:50 Ultra VIX Short-Term

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Ultra VIX Short-Term Fut ETF Proshares (UVXY) 44.50 $UVXY

The 'Yellen Effect' Revitalizes Wall Street, for Now
at The Street - Wed May 07, 4:29PM CDT
The head of the Federal Reserve made sure she said all the right things.

This Stock Market Is Not for Amateurs, Part 2
at The Street - Mon May 05, 4:44PM CDT
Stock market volatility remains. How's your risk management process doing?

This Stock Market Is Not for Amateurs
at The Street - Fri May 02, 5:10PM CDT
This 2014 stock market is disfunctional. The indices are extremely volatile, with no clear direction.

Time to Tread Carefully in This Stock Market
at The Street - Thu May 01, 4:25PM CDT
The DJIA and the S&P 500 remain in overbought territory. The Nasdaq is close behind, with the Russell 2000 far behind and weak.

Temper Dow Growth Optimism on Volume Concerns
at The Street - Wed Apr 30, 5:40PM CDT
The Dow closed at a new 2014 high, but with lack of buying volume, traders and investors need to be cautious.

The Market's Winning Streak Ends
at The Street - Wed Apr 23, 4:17PM CDT
The winning streak for the Nasdaq, Russell 2000, and the S&P 500 ended on Wednesday at six days in a row. Volume was pathetic once again, which is a very bad sign.

S&P, Nasdaq, Russell on 6-Day Win Streak
at The Street - Tue Apr 22, 4:22PM CDT
Volume, however, continues to be a major concern on the upside.

Carnage in the Nasdaq and Russell 2000 Indexes
at The Street - Mon Apr 07, 4:12PM CDT
The selling continued as both the Nasdaq and Russell 2000 have entered into Trend Bearish territory.

DJIA and S&P Finally Succumb to the Nasdaq and Russell 2000
at The Street - Fri Apr 04, 4:12PM CDT
The DJIA and S&P 500 finally see some serious selling pressure.

DJIA, S&P 500 Continue to Outperform Others
at The Street - Thu Apr 03, 4:48PM CDT
The DJIA and the S&P 500 continue to outperform the Nasdaq and Russell 2000 on a daily basis. This is not good news for the intermediate term.

Volatility ETFs Crash as Market Fears Drop - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Wed Feb 19, 1:00PM CST
Thanks to declining worries about the market, volatility ETNs have lost all of their 2014 momentum.

Volatility ETFs Skyrocket on Broad Market Weakness - ETF News And Commentary
Eric Dutram - Zacks Investment Research - Mon Feb 03, 9:00AM CST
Inside the incredible run in the volatility ETF market over the past ten days.

What This Indicator Is Saying About the S&P 500
Lee Samaha, The Motley Fool - Motley Fool - Mon Dec 30, 6:00PM CST
There is no such thing as a magic indicator that will tell you when to buy and sell the S&P 500 , and we Fools do not recommend timing the market. However, Foolish investors can use the following indicator to decide whether to be fearful of a...

The Two Month VIX Cycle
Chad Karnes - ETFG - Fri Nov 15, 7:37PM CST
Buying the VIX is a great way to hedge your portfolio, if you can get the timing right. Luckily, the VIX has provided us some excellent technical clues that we can combine with the uncertainty from Washington to come up with some great VIX trades.

Are VIX Traders Riding the Wrong Roller Coaster?
Ron DeLegge - ETFG - Thu Oct 24, 9:58PM CDT
We highlight the performance discrepancies between the VIX and VIX ETPs and why traders need to understand the difference.

Is a Fearless Stock Market Cause for Concern?
Chad Karnes - ETFG - Wed Aug 14, 7:38PM CDT
The VIX can often signal a peak in stock market prices. By flipping it, it will typically move up and down along with the market and can sometimes be easier to help identify major market turning points.

Volatility Is On My Mind - Analyst Blog
Nick Kalivas - Zacks Investment Research - Fri Aug 02, 3:45PM CDT
S&P 500 30 day historical volatility is getting low. It???s worth watching.

A Common Sense View for Investing in Stocks
Chad Karnes - ETFG - Tue Jun 18, 3:31PM CDT
A little common sense can go a long way. After a 4 year non-stop market rally, long-term investors really should take a step back and wonder if they are just chasing returns or actually making good purchase decisions.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Elite Robots Expands Global Reach with Mobile Manipulators

Updated Category News Views 105

Robots Hitting the Road? Picture this: robots that aren't just bolted to a factory floor but roam the production lines like tireless workers on wheels. That's what Elite Robots is betting on with their shiny new ELITEMISSION mobile manipulators. Not Just Any Old Robot These bad boys combine a robotic arm with an autonomous mobile platform. Think of an octopus getting off...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 228

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading
Lululemon Faces Class Action over Alleged Missteps

Updated Category News Views 13

Trouble Brewing for Lululemon Y'ever get that gut feeling when something doesn't smell right? Well, Lululemon Athletica (NASDAQ: LULU) investors are probably feeling that now. A class action's kicking up dust over what some are saying was a downright bumpy ride. The brainiacs at Robbins LLP urge those who've lost bucks riding the LULU train to step forward ahead of the...

Continue Reading
Fapon's MEDICA 2026 Bid: Game-Changer or Same Old?

Updated Category News Views 147

Fapon's Ambitious Pitch at MEDICA: A Real Deal? MEDICA 2026 sees Fapon stepping up, laden with flashy promises and hardened expertise. Set up in Düsseldorf, these folks are pushing their Local Manufacturing Solutions harder than a door-to-door vacuum seller. The main pitch? Bolstering local IVD production with their comprehensive tech transfer services. How many outfits...

Continue Reading
Dr. Kumar Joins Florida Cancer Specialists Team

Updated Category News Views 29

Welcoming a New Oncology Specialist to Bradenton What does a small but mighty addition mean for cancer care in Bradenton, Florida? Well, it feels like a big win for the locals. Dr. Vinod Kumar is the latest name to join the ranks of the Florida Cancer Specialists & Research Institute (FCS) at the Bradenton Cancer Center. With years under his belt in medical oncology and...

Continue Reading
Tips for a Dementia-Friendly Thanksgiving Gathering

Updated Category News Views 28

Thanksgiving's supposed to bring families round the table, right? But toss a few knuckleheads together, add a pinch of dementia, and suddenly it's like throwing dice at a craps table. The American Speech-Language-Hearing Association (ASHA) reckons they've got tricks up their sleeve to keep the holiday from unraveling. The Thanksgiving Reality Check The hustle, bustle, and...

Continue Reading
ICEYE Launches Gen5 SAR Satellite for Unrivaled Clarity

Updated Category News Views 60

Well, if you've been sleeping under a rock and missed the news, ICEYE just dropped another bombshell in the satellite biz. Gen5 is the name of the game, and it's claiming the spotlight for its razor-sharp imaging prowess. Now, we're talking about a satellite that supposedly snaps pictures with a resolution as fine as 11 cm. That's like spotting a flea on a dog's back from...

Continue Reading
Carolina Pines Tackles Rural Healthcare Myths on TV

Updated Category News Views 47

Rural Healthcare Battles the Big City Myth Picture this: you're in a tiny town where everyone knows your dog's name, but some think you've got to head to the city for top-notch medical care. That's where Carolina Pines Regional Medical Center steps in. They’ve snagged a spot on 'All Access with Andy Garcia', shining a light on how investments in tech and talent keep...

Continue Reading
2GenPen's Patent Push: Transforming Credit Analysis

Updated Category News Views 7

Changing the Game in Credit Analysis When you hear about a company snagging a patent, it's usually a big whoop-de-do; but 2GenPen's latest achievement is making some serious waves. This isn't some 'pat-yourself-on-the-back' sort of news – it's got teeth in the world of finance. These folks just locked down their second U.S. patent, number 12,784,096, and it's all about...

Continue Reading
Flagship's £100M London Move to Ignite AI Ventures

Updated Category News Views 131

London Calling: Flagship's New Venture Flagship Pioneering, the brain behind bustling biotech ventures like Moderna, is planting its flag in London. They're launching Flagship Origination Lab, U.K., their first real gig outside good ol' Cambridge, Massachusetts. They're diving in headfirst, sprinkling a whopping £100 million to brew up AI-native platform companies. And...

Continue Reading

Top 5 Most Recently Viewed Articles

Empowering Innovation: Schneider Electric's Climate Tech Event

Updated Category News Views 170

Exploring the Excitement of the Climate Tech in the City Event The Climate Tech in the City event embodies the spirit of innovation, uniting key players in the climate technology sector. Leading organizations like Schneider Electric are at the forefront, showcasing groundbreaking advancements and sustainable practices. This year's gathering promises a vibrant day filled...

Continue Reading
Ouster Transforms Chattanooga into a Smart Traffic Hub

Updated Category News Views 404

Ouster's Groundbreaking Initiative in Smart Traffic Management In a significant development for urban traffic management, Ouster, Inc. (NASDAQ: OUST), recognized for its state-of-the-art lidar sensors, has launched a transformative project in Chattanooga. This venture stands out as the largest lidar-enabled traffic system in the United States, boasting a remarkable...

Continue Reading
Bicara Therapeutics Business Highlights and Q1 2025 Financial Review

Updated Category News Views 520

Bicara Therapeutics Announces Key Developments and Q1 2025 Financial Results Latest data from ongoing clinical trials to be showcased at upcoming conferences. Strong financial position enables sustained development through 2029. Bicara Therapeutics Inc. (Nasdaq: BCAX), a pioneering clinical-stage biopharmaceutical firm, focuses on delivering groundbreaking bifunctional...

Continue Reading
IO Biotech Gears Up for December Conferences: Insights and Highlights

Updated Category News Views 148

IO Biotech Prepares for Key Investor Conferences IO Biotech, a trailblazer in developing groundbreaking immune-modulatory cancer vaccines, is set to join two prominent investor events this December. The company, listed under NASDAQ: IOBT, is known for its innovative approach in the biopharmaceutical industry, particularly in creating off-the-shelf therapeutic cancer...

Continue Reading
Cardinal Energy Secures $40 Million Through Latest Debenture Offering

Updated Category News Views 267

Cardinal Energy Ltd. Announces a Major Offering Cardinal Energy Ltd. is excited to inform investors about its latest initiative aimed at raising funds through a significant offering. The company has entered into an agreement with a selected group of underwriters who will help facilitate the sale of $40 million in senior subordinated unsecured debentures. This strategic...

Continue Reading